Digital biomarkers for post-licensure safety monitoring

Drug Discovery Today(2022)

引用 3|浏览0
暂无评分
摘要
•Post-licensure safety data are paramount for the safe use of medicines.•Capturing richer data would facilitate earlier and more-reliable safety insights.•Digital personal health-related data are often collected but not necessarily used in safety evaluation.•Broader use of these data could facilitate approaches to the safety assessment of medicines.
更多
查看译文
关键词
Digital health tools,Digital biomarkers,Safety,Pharmacovigilance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要